Form4insider filings, from the source

SEC Form 4 · accession 0000921895-17-001277

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Apr 17, 2017
Accepted (ET)
May 3, 2017 · 6:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F5Apr 17, 2017L170$6.51A83,278IBy: Separately Managed Account
Common StockF1,F5Apr 19, 2017L2$6.51A83,280IBy: Separately Managed Account
Common StockF1,F5Apr 21, 2017L23$6.51A83,303IBy: Separately Managed Account
Common StockF1,F5Apr 28, 2017L5$6.51A83,308IBy: Separately Managed Account
Common StockF6May 1, 2017M10,522—A30,749D
Common StockF7,F8May 1, 2017F3,683$6.59D27,066D
Common StockF1,F2holding———1,666,755IBy: Lone Star Value Investors, LP
9.00% Series A Cumulative Preferred StockF2holding———363,611IBy: Lone Star Value Investors, LP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF6—May 1, 2017M10,522A——Common Stock10,5220D

Explanation of responses